Causes and impact of delays during the COVID‐19 pandemic on head and neck cancer diagnosis
Head & Neck · 2024-09 · 46 (9) · 2197-2205
DOI: 10.1002/hed.27784 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, online erschienen am 25.04.2024. Verfasst von Maru Gete und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Hospital, University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: COVID-19, Head and Neck Neoplasms, Delayed Diagnosis, Neoplasm Staging. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The causes for delays during the COVID19 pandemic and their impact on head and neck cancer (HNC) diagnosis and staging are not well described.
Methods
Two cohorts were defined a priori for review and analysis—a Pre‐Pandemic cohort (June 1 to December 31, 2019) and a Pandemic cohort (June 1 to December 31, 2020). Delays were categorized as COVID‐19 related or not, and as clinician, patient, or policy related.
Results
A total of 638 HNC patients were identified including 327 in the Pre‐Pandemic Cohort and 311 in the Pandemic Cohort. Patients in the Pandemic cohort had more N2‐N3 category (41% vs. 33%, p = 0.03), T3‐T4 category (63% vs. 50%, p = 0.002), and stage III‐IV (71% vs. 58%, p < 0.001) disease. Several intervals in the diagnosis to treatment pathway were significantly longer in the pandemic cohort as compared to the Pre‐Pandemic cohort. Among the pandemic cohort, 146 (47%) experienced a delay, with 112 related to the COVID‐19 pandemic; 80 (71%) were clinician related, 15 (13%) were patient related, and 17 (15%) were policy related.
Conclusions
Patients in the Pandemic cohort had higher stage disease at diagnosis and longer intervals along the diagnostic pathway, with COVID‐19 related clinician factors being the most common cause of delay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
- Department of Radiation Therapy, Princess Margaret Cancer Centre/University of Toronto, Toronto, Canada.
- Department of Otolaryngology-Head and Neck Surgery/Surgical Oncology, Princess Margaret Cancer Centre/University of Toronto, Toronto, Canada.
- Department of Radiation Oncology, Princess Margaret Cancer Centre/University of Toronto, Toronto, Canada.
- Department of Biostatistics, Princess Margaret Cancer Centre / University of Toronto, Toronto, Canada.
- The Michener Institute / University of Toronto, Toronto, Canada.
ORCID-Profile: Ezra Hahn
Zitieren
APA
Gete, M., Huang, S. H., Ringash, J., Irish, J., Su, J., Ballal, Y., Waldron, J. N., Witterick, I., de Almeida, J., Hosni, A., Hope, A. J., Monteiro, E., Cho, J., O'Sullivan, B., Kim, J., Bratman, S., Goldstein, D. P., McPartlin, A., Tsai, J., …, & Hahn, E. (2024). Causes and impact of delays during the COVID‐19 pandemic on head and neck cancer diagnosis. Head & Neck, 46(9), 2197-2205. https://doi.org/10.1002/hed.27784
Vancouver
Gete M, Huang SH, Ringash J, Irish J, Su J, Ballal Y, et al. Causes and impact of delays during the COVID‐19 pandemic on head and neck cancer diagnosis. Head & Neck. 2024;46(9):2197-2205. doi:10.1002/hed.27784
BibTeX
@article{Gete2024,
author = {Gete, Maru and Huang, Shao Hui and Ringash, Jolie and Irish, Jonathan and Su, Jie and Ballal, Yashi and Waldron, John N and Witterick, Ian and de Almeida, John and Hosni, Ali and Hope, Andrew J and Monteiro, Eric and Cho, John and O'Sullivan, Brian and Kim, John and Bratman, Scott and Goldstein, David P and McPartlin, Andrew and Tsai, Jillian and Tong, Li and Xu, Wei and Hahn, Ezra},
title = {Causes and impact of delays during the COVID‐19 pandemic on head and neck cancer diagnosis},
journal = {Head & Neck},
year = {2024},
volume = {46},
number = {9},
pages = {2197--2205},
doi = {10.1002/hed.27784}
}
EUVIMED